Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...

ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...

Treatment with fenebrutinib in a 2-year open-label extension study led to significantly reduced disease-related inflammatory activity in those with relapsing MS, according to speaker at ECTRIMS ...

As reported by NeurologyLive®, neurofilament light chain (NfL) may prove to be a more reliable marker for disease progression and treatment indication in multiple sclerosis (MS) than MRI. The serum ...

OAK BROOK, Ill. – A new neuroimaging technique can detect biochemical changes in the brains of people with multiple sclerosis (MS) early in the course of the disease, paving the way for faster ...

There’s a spring in former Carson High School teacher Phil Brady’s step now that he doesn’t have to rely on his wheelchair ...

What should healthcare providers consider when advising patients at risk of or diagnosed with MS regarding the use of exogenous hormones, such as oral contraceptives, and their potential impact on ...

Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the ...

It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible in order to delay progression of the disease. The technique of magnetic resonance imaging (MRI) plays a key ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...